Site directed mutagenesis
The human gene encoding hGMD was sub-cloned into the SGC expression vector (pLIC-SGC1-hGMD)
encoding an N-terminally His 6 -TEV-tagged version of the enzyme (see the protein sequence). The plasmid was transformed into E. coli BL21(DE3) Gold and transformants were selected on LB-Amp (0.1 mg/mL) plates. Site directed mutagenesis was performed according to the modified Quick change protocol 1 using Q5 polymerase and primers listed below (the mutant triplet codon is underlined). Chalfont, UK), mounted on an ÄKTA prime plus (GE Healthcare) system operated at 3 mL/min. Columns were equilibrated with buffer A. Non-specifically bound protein was eluted using 15 column volumes of buffer B (10 mM HEPES, pH 7.5, containing 500 mM NaCl, 30 mM imidazole, 0.1 mM TCEP). hGMD was eluted using 5 column volumes of buffer C (10 mM HEPES, pH 7.5, containing 500 mM NaCl, 300 mM imidazole, 0.1 mM TCEP). Fractions containing the target protein were pooled and concentrated with Amicon Ultra-15 Centrifugal Filter Units (Merck Millipore, Billerica, MA, USA) to a total volume of 2 mL.
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They were loaded onto a size exclusion column (Superdex 200, 16/60, 120 mL; GE Healthcare) mounted onto an ÄKTA prime plus (GE Healthcare) system and equilibrated in crystallization/storage buffer (10 mM HEPES, pH 7.5, 500 mM NaCl, 5% glycerol, 0.1 mM TCEP). The system was operated with a flow rate of 0.8 mL/min at 4°C. Protein elution was monitored at 280 nm. The main hGMD fraction, eluting between 60-80 mL (corresponding to a dimer), was concentrated with Amicon Ultra-15 Centrifugal Filter Units (Merck Millipore) to a total protein concentration of 15 mg/mL and aliquoted in 70 µL portions. These were stored at -70°C until further use. Purity of the protein preparations was verified by SDS-PAGE (Fig. S1 ).
NahK expression and purification
The expression plasmid for a His 6 -tagged version of NahK 2 from Bifidobacterium longum JCM1217 was kindly provided by Dr. Motomitsu Kitaoka (National Food Research Institute, Ibaraki, Japan). The plasmid was transformed into E. coli BL21(DE3)pLysS. Recombinant NahK was produced in 1-L baffled shaken flasks (250 mL medium, inital OD 600 0.1) at 37°C and 110 rpm using Lennox media containing 0.05 mg/mL of kanamycin. At an OD 600 of 0.8, the temperature was decreased to 18°C and gene expression was induced with 0.4 mM IPTG for 20 h. Cells were harvested by centrifugation at 2,000 g at 4°C for 30 min using a Sorvall RC-5B refrigerated super speed centrifuge (Dupont Instruments). Cell disruption and immobilized Ni affinity chromatography (IMAC) were performed as described above for hGMD. Following affinity purification, an additional anion exchange (AEX) purification was performed to eliminate potentially contaminating phosphatases. Therefore, fractions from IMAC containing the NahK were pooled, and concentrated. Using Amicon Ultra-15 Centrifugal Filter Units (10 kDa cut-off; Millipore) buffer was exchanged to 50 mM HEPES, pH 7.5, and total volume concentrated to 10 mL. The sample was applied to a 5 mL HiTrap Q HP AEX column (GE Healthcare) mounted onto an ÄKTA prime plus (GE Healthcare) system and equilibrated in 50 mM HEPES buffer, pH 7.5. Bound protein was eluted using a linear gradient (0 -1 M NaCl) over 15 column volumes. The system was operated with a flow rate of 0.8 mL/min at 4°C.
Protein elution was monitored at 280 nm. Fractions containing pure NahK were pooled and concentrated and buffered into 20 mM Tris-HCl (pH 7.8) containing 150 mM NaCl and 5 mM MgCl. Amicon Ultra-15
Centrifugal Filter Units (10 kDa cut-off; Millipore) were used. 70 µL portions (30 mg/mL) were stored at -70°C until further use.
The NahK assay was performed at 37°C in 50 mM HEPES buffer (pH 7.0) containing 2 mM MgCl 2 . The substrates used were ATP (10 mM) and Man (10 mM). One unit of NahK activity is the amount of enzyme producing 1 μmol of -mannose 1-phosphate/min under the conditions used. The enzyme preparation had a specific activity of 0.02 U/mg.
ManC expression and purification
A His 6 -tagged variant of E. coli ManC was used. Expression and purification were performed as described earlier. 3 The ManC assay was performed at 37°C in 50 mM HEPES buffer (pH 7.0) containing 2 mM MgCl 2 .
The substrates used were GTP (10 mM) and -mannose 1-phosphate (10 mM). One unit of ManC activity is the amount of enzyme producing 1 μmol of GDP-Man/min. The enzyme preparation used had a specific activity of 6 U/mg.
Pyrophosphatase (PPase) expression and purification
A Strep-tagged variant of E. coli PPase was used. Expression and purification were performed as described earlier. 3 One unit of PPase activity is the amount of enzyme releasing 2 μmol of phosphate/min from 10 mM pyrophosphate in 50 mM HEPES buffer (pH 7.0, 37°C) containing 2 mM MgCl 2 . The enzyme preparation used had a specific activity of 6 U/mg.
Protein concentration measurement by absorbance at 280 nm
The protein concentrations were determined spectrophotometrically at 280 nm using a DeNovix, DS-11+ 
Crystallization and data collection
Purified wildtype hGMD and variants thereof (E157Q, S156D) were crystallized using the sitting drop vapour diffusion method. Co-crystallization was performed using 13 mg/mL enzyme, 1 mM NADP + and 5 mM GDP-4''-deoxy-4''-fluoro -mannose (wildtype enzyme) or GDP-Man (E157Q variant). To obtain the hGMD-product complex, wildtype enzyme was incubated with 5 mM GDP-Man at 37°C, two hours before the crystallization plates were set up. Sitting drops were set up in 96-well 3-drop SWISSCI crystallization Table S1 .
Structure determination and refinement
The structure of hGMD was determined by molecular replacement with PHASER 8 using PDB ID 1T2A as a search model. Model building was performed with COOT 9 and refinement was carried out with phenix.refine 10 . Ligand restraints for GDP-Man (Ligand ID: GDD), GDP-4''-deoxy-4''-fluoro-mannose (Ligand ID: G4F) and GDP-6''-deoxy-D-lyxo-hexos-4''-ulose (GDP-4''-keto-6''-deoxy-mannose; Ligand ID: F7E) were generated with the Grade Web Server 11 and the molecules were initially placed using phenix.ligand_fit 10 . Final structures were evaluated using MolProbity 12 . The numbers of Ramachandran outliers is < 0.2%. Figures of the structural models were prepared using pymol_1.3. 13 Refinement statistics of the reported structures are shown in Table S1 .
Molecular dynamics simulation
Molecular dynamics (MD) simulations were performed using YASARA dynamics. 14 The crystal structure of the E157Q variant (PDB ID: 6GPK) was used as the starting structure because the full protein, including the inhibitor loop, could be modelled in this case. To simulate the wildtype enzyme, Gln 157 was substituted in silico by Glu 157 and the resulting energy-minimized active-site architecture was evaluated using the crystallized wildtype complexes. No significant differences could be detected between the experimental and thus modelled active sites. Ligands present in the active site were modified; GDP-Man to GDP-mannos-4'',5''-ene and NADP + to NADPH, granting minimal perturbation of the crystallized complex. In each simulation, the hGMD dimer was used as this represents the native quaternary structure of the enzyme. Force field parameters of the ligands were assigned by the Yasara´s AutoSmiles approach 15, 16 implemented in YASARA (version 18.2.7). Energy minimization was done prior to each MD simulation in explicit water using the AMGER15FB 17 force field and the TIP3P water model 18 . The system was immersed in a octahedral simulation cell, which extended 10 Å on each side. The AMBER15FB force field was assigned with 8 Å van der Waals interactions cut-off, and long range electrostatic interactions were calculated using the Particle Mesh Ewald (PME) algorithm. 19 All simulated systems were neutralized to pH 7.4 by counter ions using 0.9% NaCl. Solvent density was 0.997 g/mL (at 298 K). YASARA predicted pK a values for ionizable side chains (E, D, H and K) 20 . However, the protonation states of Glu 157 (protonated) and Tyr 179 (deprotonated)
were chosen according to the simulated reaction step. The constant simulation temperature of 298 K was set by assigning random velocity vectors to all atoms using a Maxwell-Boltzmann distribution and a Berendsen thermostat, so that the resulting kinetic energy matched the specified temperature. The time average macroscopic temperature was kept at the requested value by rescaling the atom velocities. 21 Convergence of productive MD simulations to equilibrium were evaluated by the RMSD of total energy and C atoms (see
Figs. S12 and S13). After 1 nsec of the simulation, the complex could be considered stable. The RMSD of Catoms was 1.3 (± 0.1) Å. The C atoms and key interatomic distances were evaluated every 100 psec S10 ( Fig. S13 ) and average distances were calculated from 1 to 15 ns of simulation. Average distances include both simulated chains (Table S2) .
Capillary zone electrophoresis
Capillary zone electrophoresis was performed at 50°C on an HP 3D CE system (Hewlett Packard, Palo Alto, 
Dehydratase assay
Reactions were performed at 37°C without agitation in 50 mM HEPES (pH 7.5) containing 200 mM NaCl and 1 mM TCEP. Caffeine (0.5 mM) was used as an internal standard. The reaction volume was 250 µL.
Initial rates were determined at varying GDP-Man concentrations (range 0.001 -0.1 mM). The reaction was initiated by adding hGMD dimer to 1.4 µM (wildtype). For hGMD variants, the enzyme concentration was increased to 23.5 µM for E157Q, Y179F, S156D and to 7.8 µM for S156A. Samples (10 µL) were taken at 0, Full release of the coenzyme was evaluated by a shift of the absorbance maximum from 440 nm in enzymebound NADPH to 450 nm in free NADPH (Fig. S17b) . The occupancy of NADPH in hGMD was calculated in % based on the concentration of released NADPH (in μM) divided by the total protein concentration (in μM) applied to the experiment.
Enzyme-bound NADPH at reaction steady state
Prior to each measurement, the enzyme-bound NADPH was oxidized to NADP + using GDP-4''keto-6''-deoxy-mannose as the substrate, adopting a procedure previously developed for dTDP-glucose dehydratase. 22 Once the oxidation was complete, sugar nucleotides were removed by washing the enzyme 3 times with a 10-fold volumetric excess of 50 mM HEPES (pH 7.5) containing 200 mM NaCl and 1 mM TCEP. Centrifugation (16000  g, 15 min, 4 °C) with Vivaspin 500 centrifugal concentrator (10 kDa cut-off) was used. Measurement of NADPH at steady state was done in a final reaction volume of 400 µL. The enzyme concentration was 34 µM and 500 µM GDP-mannose (15-fold molar excess over enzyme dimer) was used in 50 mM HEPES (pH 7.5) containing 200 mM NaCl and 1 mM TCEP. Fluorescence was measured continuously over 1 h (λEx = 340 nm; λEm = 440 nm; Fig. S18 ). The reaction buffer and enzyme were equilibrated for 1 min until the fluorescence signal was stable and the reaction was initiated by addition of GDP-Man. To analyze the GDP-Man conversion during the experiment, samples (40 µL) were taken immediately after the reaction start and after 3600 sec. Samples were quenched in methanol and analyzed by capillary electrophoresis (Fig. S18 ).
Preparative synthesis of GDP-Man
Synthesis and product isolation was performed as described by Pfeiffer et al. 3 Purity of the lyophilized GDPMan was verified using HPLC, CE and 1 H NMR (Fig. S20 ).
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Preparative synthesis of GDP-4''-deoxy-4''-fluoro-mannose
GDP-4''-deoxy-4''-fluoro-mannose was prepared in a one-pot two-step synthesis as shown in Fig. S5 . -anomeric phosphorylation of 4''-deoxy-4''-fluoro-mannose (4 mM) was performed using 1 mM MgCl 2 , 6 mM GTP and 0.1 U of NahK in 50 mM HEPES (pH 7.5) in a total volume of 7 mL. Phosphorylation was monitored using TLC. One μL of reaction mixture was spotted directly on silica gel plates, developed using 1-propanol/n-butanol/ethanol/H 2 O = 2:3:3:2 (by volume) and stained with thymol sugar stain (5 g/L thymol, 5% H 2 SO 4 in ethanol). Phosphorylation ran to completion within 24 h (Fig. S5b) . To perform the nucleotide transfer, GTP in 5-fold molar excess over phosphorylated 4''-deoxy-4''-fluoro-mannose, 1 U ManC and 10 U PPase were added directly to the reaction mixture. Reactions were monitored using HPLC and TLC. -4''-deoxy-4''-fluoro-mannose-1-phosphate was fully converted to GDP-4''-deoxy-4''-fluoro-mannose within 20 h (Fig. S5b ). Enzymes were removed by centrifugation (20,000 g, 20 min, and 4°C) using Amicon Ultra-15 Centrifugal Filter Units (10 kDa cut-off, Merck Millipore). Purification of the GDP-4''-deoxy-4''-fluoro-mannose involved AEX and SEC chromatography followed by lyophilisation. It was performed as previously described for GDP-Man. 3 Briefly, enzyme-free reaction mixture was applied to a FliQ FPLC column (10 mL; 104 11.0 mm; Generon, Maidenhead, U.K.) packed with SuperQ-650M (Tosh, Tokyo, Japan) anion-exchange resin. The column was mounted onto an ÄKTA prime plus FPLC system (GE Healthcare) and operated with a flow rate of 1 mL/min. The column was pre-equilibrated with 20 mM sodium acetate (NaOAc), pH 4.6. Elution was done with a continuous gradient from 0% to 100% of 1 M NaOAc, pH 4.6, in a volume of 300 mL. GDP-4''-deoxy-4''-fluoro-mannose eluted at around 400 mM NaOAc (Fig. S5c) . Elution of nucleotides was monitored by absorbance at 254 nm. Fractions containing GDP-4''-deoxy-4''-fluoro-mannose were pooled and concentrated to a final volume of 6 mL under reduced pressure using a rotary evaporator (Heidolph Laborota 4001, Schwabach, Germany) at 40 °C. To remove excess NaOAc, the pooled and concentrated fractions were split into 3 2 mL portions and applied to SEC using a XR 16/1000 column (16 x1000 mm; GE Healthcare) packed with Sephadex G10 material (exclusion limit <700 Da) equilibrated in H 2 O and mounted to an ÄKTA prime plus FPLC system (GE Healthcare).
Compound elution was performed using H 2 O and monitored by absorbance at 254 nm (Fig. S5d) . Fractions containing salt-free GDP-Man were pooled and lyophilized. Purity and structural identity of the lyophilized GDP-4''-deoxy-4''-fluoro-mannose were assessed using HPLC, capillary electrophoresis, Fig. S21 and 22 ).
Preparative synthesis of GDP-4''-keto-6''-deoxy-mannose and GDP-4''-keto-5''-deutero-6''-deoxy-mannose
Reaction mixtures contained 15 mM GDP-Man, 50 mM potassium phosphate buffer (pH 7.5) and 1 U hGMD in a total volume of 2 mL. Incubation was at 37°C without agitation until a conversion of at least 95% was reached. The reactions were monitored by discontinuous sampling and analysis with capillary electrophoresis. Enzyme was removed using centrifugation (20,000 g, 20 min, 4°C) with Vivaspin 500
Centrifugal Concentrator (10 kDa cut-off). The enzyme-free reaction mixture was lyophilized without further S13 purification to avoid degradation of the relatively labile GDP-4''-keto-6''-deoxy-mannose. The resulting white powder was stored at -20°C until further use, however not longer than 1 month. The same synthesis was used for the production of GDP-4''-keto-5''-deutero-6''-deoxy-mannose, except that all reagents were prepared in D 2 O. Purity and structural identity of the lyophilized GDP-4''-keto-6''-deoxy-mannose and GDP-4''-keto-5''-deutero-6''-deoxy-mannose were assessed using HPLC, capillary electrophoresis and 1 H NMR ( Fig. S23 and S24) . 1 H NMR analysis revealed that GDP-4''-keto-6''-deoxy-mannose is in equilibrium with its diol form in aqueous solutions. The equilibrium ratio of 4''-keto/4''-diol form is about 3:1.
NMR analysis of purified sugar nucleotides
Lyophilised sugar nucleotides were dissolved to 3 -10 mM in 50 mM potassium phosphate buffer (pD 7.9) in a total volume of 600 µL. They were analyzed using a Varian (Agilent) INOVA 500-MHz NMR spectrometer (Agilent Technologies). The VNMRJ 2.2D software was used for measurements. 
In situ 1 H NMR analysis of hydrogen/deuterium exchange at the C''5 of GDP-4''-keto-6''-deoxy-mannose
Enzymatic conversion of GDP-4''-keto-6''-deoxy-mannose (produced in H 2 O) to GDP-4''-keto-5''-deutero-6''-deoxy-mannose were analyzed by 1 H-NMR (Fig. S27 -S29 ). For this, all reagents including hGMD were dissolved ein D 2 O. The hGMD was rebuffered by a three-fold washing of the enzyme with 10-fold excess of potassium phosphate buffer (50 mM; pD 7.9) using centrifugation (16000  g, 15 min, 4 °C) with
Vivaspin-500-centrifugal concentrator (10 kDa cut-off). The reaction mixtures contained 3 mM GDP-4''-keto-6''-deoxy-mannose (produced in H 2 O) and wildtype enzyme (1.4 µM) in a final volume of 600 μL potassium phosphate buffer (50 mM; pD 7.9). For reactions of the hGMD variants, the enzyme loading was increased as follows: S156D (4.7 µM), S156A ( 
Binding of GDP-4''-deoxy-4''-fluoro-mannose to hGMD monitored with isothermal titration calorimetry (ITC)
Binding of GDP-4''-deoxy-4''-fluoro-mannose to wildtype hGMD was analysed using a PEAQ-ITC system (MicroCal, Malvern, UK). Experiments were performed at 25°C in 150 mM sodium phosphate buffer (pH . Note: all enzymes were pre-incubated with GDP-4''-keto-6''-deoxy-mannose to oxidize the NADPH present in the enzyme as isolated. This oxidation was possible for wild-type enzyme and the S156A and S156D variants (panels a, b and c). Due to lacking activity in the enzymes, this oxidation was not possible for the Y179F and the E157Q variants. These latter variants therefore retained enzymebound NADPH before being used in the assay with GDP-Man (panels d and e). For details of the procedures used, please see on page S11 the section Enzyme-bound NADPH at reaction steady state. a) Wildtype and b) S156A retain their (very low) amount of initial NADPH present in the enzymes while full conversion of GDP-Man occurs within 3600 s. c) S156D shows retention of the (very low) initial NADPH without conversion of GDP-Man within 3600 s. d) Y179F and e) E157Q were not oxidized and exhibit an initial NADPH occupancy of 70% an 49%, respectively. Both enzymes show a constant NADPH content, without conversion of GDP-Man during 3600 s of incubation. CE traces show peaks (blue trace measured at 253 nm) corresponding to (1) GDP-Man and (2) GDP-4''-keto-6''-deoxy-mannose; as injection volumes are not tightly controlled, areas under the peak of GDP containing compounds are used to calculate conversions. The red trace corresponds to the current during the measurement. GDP-4''-keto-6''-deoxy-mannose, (3b) GDP-4''-diol-6''-deoxy-mannose. The typical 6-H'' doublet of (3a) GDP-4''-keto-6''-deoxy-mannose and the hydrated form (3b) GDP-4''-diol-6''-deoxy-mannose stays the same over the whole incubation time. This indicates that the enzyme has lost the ability to catalyze deuterium exchange at the C5''.
Figure S28. In-situ 1 H-NMR time course of deuterium wash-in into C5'' of GDP-4''-keto-6''-deoxymannose catalyzed by S156D variant (4.7 µM): (3a) GDP-4''-keto-6''-deoxy-mannose, (3b) GDP-4''-diol-6''-deoxy-mannose, (4a) GDP-4''-keto-5''-deutero-6''-deoxy-mannose, (4b) GDP-4''-diol-5''-deutero-6''-deoxy-mannose. With time of reaction, the typical 6-H'' doublet of (3a) GDP-4''-keto-6''-deoxy-mannose and the hydrated form (3b) GDP-4''-diol-6''-deoxy-mannose is transformed to a singlet, indicating formation of (4a) GDP-4''-keto-5''-deutero-6''-deoxy-mannose (4b) and GDP-4''-diol-5''-deutero-6''-deoxy-mannose. This is evidence of deuterium exchange at C5''.
Figure S29. In-situ 1 H-NMR time course of deuterium wash-in into C5'' of GDP-4''-keto-6''-deoxymannose catalyzed by S156A variant (35 µM): (3a) GDP-4''-keto-6''-deoxy-mannose, (3b) GDP-4''-diol-6''-deoxy-mannose, (4a) GDP-4''-keto-5''-deutero-6''-deoxy-mannose, (4b) GDP-4''-diol-5''-deutero-6''-deoxy-mannose. With time of reaction, the typical 6-H'' doublet of (3a) GDP-4''-keto-6''-deoxy-mannose and the hydrated form (3b) GDP-4''-diol-6''-deoxy-mannose is transformed to a singlet, indicating formation of (4a) GDP-4''-keto-5''-deutero-6''-deoxy-mannose (4b) and GDP-4''-diol-5''-deutero-6''-deoxy-mannose. This is evidence of deuterium exchange at C5''. Figure S30 . Proposed mechanism of -elimination via an initial enolization step in hGMD and its possible application to the reaction of dTDP-glucose-4,6-dehydratase (RmlB). Both hGMD and RmlB utilize a conserved Glu as general catalytic base in the enolization step. In hGMD, the Glu is the general acid in the subsequent 1,4-elimination, describable according to this study as a vinylogous E2 reaction (see Gerlt and Gassman 23 ). Once the Glu has abstracted the proton from C5'', it changes its conformation slightly to be able act as general acid for the elimination of water. Note: our MD simulations have captured this conformational flexibility of the Glu for hGMD. RmlB differs from hGMD by the presence of an acidic residue (Asp) in the active site as shown. The Asp has been considered as the catalytic acid for the elimination of water (see ref 24 in this Supporting Information and references therein). However, the possibility that the Glu moves into the immediate vicinity of the Asp when it adopts the conformation required for general acid catalysis to water elimination was not considered. Assuming this to occur, the presence of Asp in RmlB is expected to increase the pK a of the Glu as compared to its value in hGMD. From previous analyses of similar residue arrangements in the active sites other enzymes (e.g., hexosaminidases; see main text) the effect on pK a enhancement is expected to be substantial (several log units). The mechanistically relevant consequence of the pK a increase in Glu according to the scenario proposed is that enolization of the ketone formed in the initial step of enzyme catalysis, specifically the proton transfer from C5'' to Glu, becomes thermodynamically more favorable. This is indicated in the figure as a change in the internal equilibrium for enolization of the enzyme-bound intermediates in RmlB as compared to hGMD. Note that the true equilibrium of the enolization is not known and we intend to show here only the relative effect between the two enzymes. In the case that the overall reaction rate constant (k cat ) is limited by oxidation-enolization, as in hGMD, modulating the pK a of the Glu appears to be a chemically sound strategy, perhaps used in natural evolution of dehydratases with just that selection principle, to enhance the enzymatic rate. Since an elevated pK a of Glu would make proton transfer to the water leaving group less favorable in the subsequent elimination step, as indicated in the figure, ability of the Glu to engage in both general base and general acid catalysis must be a balanced one. In RmlB, however, the Asp was proposed to function as the catalytic acid for elimination. 24 We note that stabilization of the protonated Glu in a conformation bonded to Asp, as shown in the figure, could have the consequence that enolization and elimination become strongly coupled (concerted) steps of the overall enzymatic reaction. This would allow -elimination via enolization to be reconciled with the experimental observations of concerted reaction of wildtype dTDP-glucose-4,6-dehydratase. 
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